Option chain shows key data for Telix Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Telix Pharmaceuticals.

Telix Pharmaceuticals (NASDAQ:TLX) Stock, Option Chain

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Telix Pharmaceuticals

A,3d,Illustration,Depicting,Cancer,Cells,In,The,Crosshairs,,Related

Analyst Color

Biotech

News

Health Care

Analyst Ratings

Trading Ideas

General

Telix reports early Phase 2 data showing TLX101 improves survival in recurrent brain cancer patients, with no serious side effects observed.

Telix Pharmaceuticals Touts Encouraging Data From Investigational Radiation Therapy In Relapsed Brain Cancer Patients

AerovironmentRichmond,,Virginia,,Usa,-,8,May,2019:,Illustrative,Editorial,Of

Equities

Mid Cap

Movers

AVAV

CERT

LOAR

ORLA

RXRX

RYTM

SBSW

STRL

Top mid-cap stock performers last week: AGL, RXRX, CERT, AVAV, STRL, ORLA, IAG, SBSW, LOAR, RYTM, TLX. High gains due to positive news and macro uncertainty.

These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio?

Five,Below,Now,Open,-,Closeup,Of,Sign,On,Building

Intraday Update

Markets

ANNA

BELFA

CAMT

DLTR

FIVE

GOGL

NMAX

NVGS

USAR

YALA

Five Below, Telix Pharmaceuticals, Dollar Tree And Other Big Stocks Moving Higher On Monday

Telix Pharmaceuticals Limited - American Depositary Shares

Telix Pharmaceuticals Ltd

NEW MURCHISON GOLD LTD by NEW MURCHISON GOLD LTD

New Murchison Gold Ltd

Press Releases

FDA Approves New Prostate Cancer Imaging Agent Gozellix®

ARTMS Drug Master File for Gallium Production Technology Referenced with Telix's Gozellix®

Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma

Management

Anne Whitaker Appointed as Non-Executive Director

Telix Appoints Paul Schaffer as Chief Technology Officer

Telix Announces Cardinal Health for Gozellix Commercial Distribution

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

Earnings

Telix Reports US$186M Q1 Revenue, Up 62% YOY

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

ICLR

ADMA Biologics

Alkermes

Ascendis Pharma A/S - American Depositary Shares

Ascendis Pharma

BridgeBio Pharma

BioMarin Pharmaceutical Inc. - Common Stock

Biomarin Pharmaceutical

Blueprint Medicines Corporation - Common Stock

Blueprint Medicines

Cytokinetics, Incorporated - Common Stock

Cytokinetics

Exact Sciences Corporation - Common Stock

Exact Sciences

Exelixis

Grifols, S.A. - American Depositary Shares

Grifols

Halozyme Therapeutics, Inc. - Common Stock

Halozyme Therapeutics

Ionis Pharmaceuticals, Inc. - Common Stock

Ionis Pharmaceuticals

Krystal Biotech

Legend Biotech Corporation - American Depositary Shares

Legend Biotech

Madrigal Pharmaceuticals, Inc. - Common Stock

Madrigal Pharmaceuticals

Moderna

Nuvalent

Vaxcyte

Roivant Sciences

Revolution Medicines, Inc. - Common Stock

Revolution Medicines

Rhythm Pharmaceuticals, Inc. - Common Stock

Rhythm Pharmaceuticals

Soleno Therapeutics

Sarepta Therapeutics, Inc. - Common Stock

Sarepta Therapeutics

SpringWorks Therapeutics, Inc. - common stock

Comments

Telix Pharmaceuticals

Telix Pharmaceuticals (TLX) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell